Trial intelligence / Profile preview

Topical simvastatin emulsion for atopic dermatitis

RBR-7qzb27mPhase 3Recruiting

Sponsor
Universidade Estadual de Campinas
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of simvastatin in atopic dermatitis (AD), sponsored by Universidade Estadual de Campinas. Started Jul 2022; status: recruiting.

02

Drugs

simvastatin
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on RBR-7qzb27m.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7qzb27m.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call